deoxycytidine and Menopause

deoxycytidine has been researched along with Menopause in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albain, KS; Bedard, PL; Cardoso, F; Costa, A; Cufer, T; Fallowfield, LJ; Kyriakides, S; Pagani, O; Senkus-Konefka, E; Winer, EP1
Bozec, L; Campone, M; Diéras, V; Espié, M; Fumoleau, P; Kayitalire, L; Petit, T; Pouillart, P; Pujade-Lauraine, E; Serin, D; Viens, P1
Bonadonna, G; Brambilla, C; Demicheli, R; Gianni, L; Marchianò, A; Mariani, G; Tagliabue, P; Valagussa, P; Villa, E; Zucchinelli, P1

Reviews

1 review(s) available for deoxycytidine and Menopause

ArticleYear
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
    Journal of the National Cancer Institute, 2009, Sep-02, Volume: 101, Issue:17

    Topics: Age Factors; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Capecitabine; Comorbidity; Congresses as Topic; Cross-Over Studies; Deoxycytidine; Drug Administration Schedule; Europe; Evidence-Based Medicine; Female; Fluorouracil; Humans; International Cooperation; Karnofsky Performance Status; Menopause; Patient Selection; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Socioeconomic Factors; Taxoids; Vinblastine; Vinorelbine

2009

Trials

2 trial(s) available for deoxycytidine and Menopause

ArticleYear
Gemcitabine and epirubicin in patients with metastatic breast cancer: a phase I/II study.
    Breast (Edinburgh, Scotland), 2006, Volume: 15, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; France; Gemcitabine; Humans; Infusions, Intravenous; Menopause; Middle Aged; Neoplasm Metastasis; Treatment Outcome

2006
Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer.
    Breast cancer research and treatment, 2001, Volume: 70, Issue:3

    Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Maximum Tolerated Dose; Menopause; Middle Aged; Vinblastine; Vinorelbine

2001